Advertisement

Topics

Tessa, Parker Institute sign deal on cell therapies, immuno-oncology studies

06:04 EDT 20 Jun 2017 | SmartBrief

Tessa Therapeutics has signed a multiyear agreement with the Parker Institute for Cancer Immunotherapy to develop cell therap -More

Original Article: Tessa, Parker Institute sign deal on cell therapies, immuno-oncology studies

NEXT ARTICLE

More From BioPortfolio on "Tessa, Parker Institute sign deal on cell therapies, immuno-oncology studies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...